Public health authorities in Toronto have confirmed two travel-related cases of a different mpox variant for the first time in both the city and the province. The announcement marks a significant development in the monitoring of mpox infections in the region and highlights the continued importance of vaccination and public awareness.
New Mpox Variant Identified in Toronto
Toronto Public Health has reported that the two newly confirmed cases involve the clade Ib variant of the mpox virus. These cases are linked to international travel, indicating that the infections were likely acquired outside Canada.
Health officials explained that clade Ib has previously been associated with outbreaks in several regions of Central and Eastern Africa. Additionally, a limited number of travel-related infections involving this variant have been documented in Europe and other parts of the world.
The identification of clade Ib in Toronto represents the first time this particular variant has been detected in the city and the province.
Mpox Strains Previously Detected in Toronto
Since the global mpox outbreak began in 2022, all confirmed infections in Toronto had been linked exclusively to the IIb strain of the virus. The recent cases therefore signal the introduction of a different variant into the local surveillance system.
Health authorities emphasize that ongoing monitoring and testing are essential to detect new variants early and prevent further spread.
Symptoms Associated With Mpox Infection
Public health officials note that both the clade Ib and IIb variants can cause similar symptoms. Individuals infected with mpox may experience:
- Painful skin lesions or rashes
- Fever
- Flu-like symptoms such as fatigue, body aches, and chills
Anyone who develops these symptoms, particularly after international travel or close contact with an infected person, is advised to seek medical guidance.
Vaccination Encouraged for Toronto Residents
Toronto Public Health is encouraging eligible residents to receive the mpox vaccine as a preventive measure. Officials stress that the vaccine:
- Is free of charge
- Does not require a health card to receive
- Is available to eligible individuals across the city
Vaccination remains one of the most effective ways to reduce the risk of infection and limit transmission within communities.
Mpox Cases in Toronto During 2025
Health officials reported that 155 mpox cases were confirmed in Toronto in 2025. Data shows that a significant portion of these cases occurred among residents living in the downtown core of the city.
Public health authorities continue to monitor trends and encourage residents to stay informed about symptoms, prevention measures, and vaccination options.
The confirmation of Toronto’s first travel-related cases of the clade Ib mpox variant highlights the ongoing global nature of infectious disease transmission. While the IIb strain has been the primary variant seen locally since 2022, the appearance of clade Ib underscores the importance of vigilance, vaccination, and timely public health responses. By staying informed, recognizing symptoms early, and accessing available vaccines, Toronto residents can help reduce the spread of mpox and protect community health.